Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.

ABSTRACT:

Introduction

In the current coronavirus infection 2019 (COVID-19) pandemic, the messenger RNA vaccines have been shown to help protect high-risk groups from COVID-19. Among healthcare workers vaccinated with Pfizer-BioNTech COVID-19 vaccine, a survey was conducted to analyze the relationship between the incidence and severity of adverse reactions after vaccination.

Methods

We conducted a prospective self-reported survey of adverse reactions among healthcare workers vaccinated with the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Japan. After the first and second dose of vaccine, local and systemic reactions for 8 days after vaccination were reported by volunteer participants using a website. After receiving vaccination, 374 respondents participated in this matched-pair s

SUBMITTER: Maruyama A 

PROVIDER: S-EPMC8947941 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature